FFFernanda Fontenelle

Fernanda Fontenelle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fernanda Fontenelle has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Treatment adherence in individuals with cystic fibrosis: An Observational Study

    by Fernanda Fontenelle, Lucas Vieira, Adriana Faiçal, Juliana Brazil, Marcia Teixeira, Edna Lucia Souza

    Introduction: Low treatment adherence is a complex issue frequently observed in cystic fibrosis (CF) patients. Objective: To evaluate the self-reported treatment adherence rate and the rate determined based on pharmacy medication dispensation records in individuals with CF, and to investigate the association between treatment adherence and sociodemographic and clinical variables. Methods: Cross-sectional study with a consecutive sample was conducted in a CF referral center in the Northeast of Brazil. Using two methods: (1) The Morisky-Green test measured the self-reported treatment adherence for pancreatin, dornase alfa, and inhaled tobramycin; (2) dispensation records of prescribed drugs. A medication usage percentage ≥ 80% was classified as good treatment adherence. Prevalence ratios were used to assess associations between good treatment adherence and studied variables. Results: Forty-two individuals were included, 55.8% female, median age 7.3 years. Self-reported good treatment adherence for the use of pancreatin, dornase alfa, and inhaled tobramycin were 65.8%, 50.0%, and 44.4% of the participants, respectively. According to pharmacy records, the percentages of good treatment adherence were 71.4%, 66.7%, and 52.6% for the use of dornase alfa, tobramycin, and pancreatin, respectively. When comparing the methods, the agreement in treatment adherence rates for medication use ranged from 64.0% to 85.7%. Conclusion: Treatment adherence was low and varied by medication and methodology. Good adherence was mainly associated with younger age and the educational level.

  • Open Access

    Treatment adherence in individuals with cystic fibrosis: An Observational Study

    by Fernanda Fontenelle, Lucas Vieira, Adriana Faiçal, Juliana Brazil, Marcia Teixeira, Edna Lucia Souza

    Introduction: Low treatment adherence is a complex issue frequently observed in cystic fibrosis (CF) patients. Objective: To evaluate the self-reported treatment adherence rate and the rate determined based on pharmacy medication dispensation records in individuals with CF, and to investigate the association between treatment adherence and sociodemographic and clinical variables. Methods: Cross-sectional study with a consecutive sample was conducted in a CF referral center in the Northeast of Brazil. Using two methods: (1) The Morisky-Green test measured the self-reported treatment adherence for pancreatin, dornase alfa, and inhaled tobramycin; (2) dispensation records of prescribed drugs. A medication usage percentage ≥ 80% was classified as good treatment adherence. Prevalence ratios were used to assess associations between good treatment adherence and studied variables. Results: Forty-two individuals were included, 55.8% female, median age 7.3 years. Self-reported good treatment adherence for the use of pancreatin, dornase alfa, and inhaled tobramycin were 65.8%, 50.0%, and 44.4% of the participants, respectively. According to pharmacy records, the percentages of good treatment adherence were 71.4%, 66.7%, and 52.6% for the use of dornase alfa, tobramycin, and pancreatin, respectively. When comparing the methods, the agreement in treatment adherence rates for medication use ranged from 64.0% to 85.7%. Conclusion: Treatment adherence was low and varied by medication and methodology. Good adherence was mainly associated with younger age and the educational level.

  • Open Access

    Evidências em política, planejamento e gestão em saúde aplicadas à doença renal crônica: revisão de escopo

    by Luana Rodrigues Sarmento, Fernanda Maria Carvalho Fontenele, Thiciano Sacramento Aragão, Angélica Paixão de Menezes, Paula Frassinetti Castelo Branco Camurça Fernandes

    Diante do contexto histórico e epidemiológico da doença renal no Brasil, observou-se a necessidade de aprofundar na política, planejamento e gestão em saúde. Para tanto, objetivou-se mapear as iniciativas nacionais nestes campos. Trata-se de uma revisão de escopo, realizada a partir da consulta nas bases de dados Web of Science, MEDLINE, BVS, Scopus e CINAHL, por periódicos científicos e na literatura cinzenta. Selecionamos 47 publicações para extração de dados dos 604 documentos encontrados inicialmente, e organizou-se categorias. O escopo das produções acerca da política, planejamento e gestão em saúde aplicados à doença renal crônica foi se desenvolvendo ao longo dos anos, em meio a portarias, resoluções, documentos oficiais do Ministério da Saúde e artigos científicos diversos, porém incipientes diante da relevância da doença. Aponta-se o baixo interesse de pesquisa nessa área específica, assim como a necessidade de maior abordagem na política em saúde, planejamento e gestão da doença renal no Brasil, para que se tenha base científica acurada nas decisões gestoras. Acredita-se que compreender o contexto, o conceito e as características da doença renal influencie a operacionalização, governança e avaliação de desempenho na sua gestão.

  • Open Access

    TREATMENT ADHERENCE AMONG CHILDREN AND ADOLESCENTS IN A CYSTIC FIBROSIS REFERENCE CENTER

    by Bianca Sampaio Bonfim, Valmir Machado de Melo Filho, Fernanda Matos Fontenelle, Edna Lúcia Souza

    Objective: To evaluate the level of self-referenced treatment adherence (TA) and its association with clinical and sociodemographic variables in patients with cystic fibrosis assisted at a reference center, as well as compare the level of self-referenced TA with that presumed by the multidisciplinary team. Methods: This is a cross-sectional study that included children and adolescents aged between 0-20 years with cystic fibrosis. Adolescents older than 14 years or their guardians, when younger than 14 years old, were interviewed using a standardized questionnaire. Professionals from the multidisciplinary clinic filled out another form with their impressions of the patients’ TA. Clinical and laboratory data were obtained in the medical records. The TA was considered satisfactory if the total adherence index (TAI) was equal or higher than 80%. Results: 53 patients were included with a median age of 112 months. The mean TAI was 83.2%. The mean TAIs for dornase alfa, pancreatic enzymes, continued use of inhaled tobramycin, vitamins supplements, nutritional supplements and dietary orientation was respectively: 86.1; 96.6; 78.6; 88.1; 51.8 and 78%. Children younger than 14 years presented better TA (p=0.021). The correlation between the self-referenced TA and the one presumed by the multidisciplinary team ranged from 0,117 to 0.402, being higher for Psychology and Nutrition professionals. Conclusions: The TAI was high particularly among children younger than 14 years. There was a positive correlation between the self-referenced TA and the one presumed by the Psychology (p=0.032) and the nutrition (p=0.012) professionals.